CME in Minutes: Education in Primary Care

Barbara Burtness, MD - The Pan-Tumor Perspective: Looking Toward the Future of Care With HER3-Directed ADCs for Pretreated Patients With Advanced Solid Tumors


Listen Later

Please visit answersincme.com/DDP860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in oncology discusses human epidermal growth factor receptor 3 (HER3)–directed antibody–drug conjugates (ADCs) for the treatment of patients with advanced solid tumors. Upon completion of this activity, participants should be better able to: Explain the rationale for the pan-tumor use of HER3-directed treatment for patients with locally advanced or metastatic solid tumors; Review clinical trials of investigational HER3-directed ADCs in previously treated patients with advanced solid tumors; and Outline criteria that may guide the selection of HER3-directed ADCs to treat advanced solid tumors, based on available evidence.
...more
View all episodesView all episodes
Download on the App Store

CME in Minutes: Education in Primary CareBy Answers in CME

  • 4.8
  • 4.8
  • 4.8
  • 4.8
  • 4.8

4.8

5 ratings


More shows like CME in Minutes: Education in Primary Care

View all
CME in Minutes: Education in Cardiology & Pulmonology by Answers in CME

CME in Minutes: Education in Cardiology & Pulmonology

3 Listeners

CME in Minutes: Education in Oncology & Hematology by Answers in CME

CME in Minutes: Education in Oncology & Hematology

5 Listeners

CME in Minutes: Education in Dermatology by Answers in CME

CME in Minutes: Education in Dermatology

3 Listeners

CME in Minutes: Education in Rheumatology, Immunology, & Infectious Diseases by Answers in CME

CME in Minutes: Education in Rheumatology, Immunology, & Infectious Diseases

4 Listeners

CME in Minutes: Education in Ophthalmology by Answers in CME

CME in Minutes: Education in Ophthalmology

0 Listeners